Entering text into the input field will update the search result below

Precigen, Inc. (PGEN) CEO Helen Sabzevari on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 5:29 AM ETPrecigen, Inc. (PGEN)
SA Transcripts profile picture
SA Transcripts

Precigen, Inc. (NASDAQ:PGEN) Q4 2019 Earnings Conference Call March 2, 2020 5:30 PM ET

Company Participants

Steve Harasym - Vice President of Investor Relations

Helen Sabzevari - President and Chief Executive Officer

Tom Samuelson - Vice President of Finance

Conference Call Participants

Jason Butler - JMP Securities


Good afternoon, and welcome to the Precigen Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note, that this event is being recorded. I would now like to turn the conference over to Steve Harasym. Please go ahead.

Steve Harasym

Thank you, operator. Welcome to Precigen Fourth Quarter and Full Year 2019 Business and Update Call. I'm Steve Harasym, Vice President of Investor Relations, and I'm pleased to be joined today by Dr. Helen Sabzevari, President and CEO of Precigen; and Tom Samuelson, Vice President of Finance.

During today’s call, as seen on Slide 2, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated by our forward-looking statements. Please read the safe harbor statement contained in this presentation, as well as in Precigen's most recent SEC filings for a more complete discussion of these risks and uncertainties.

I would now like to turn the call over to Dr. Helen Sabzevari. Helen?

Helen Sabzevari

Thank you, Steve. Please go to Slide 3. I’m extremely pleased to be here today as we have made great progress even since our last public presentation at JPMorgan Healthcare Conference in early January. We enter 2020 with renewed optimism about our ability to deliver on our aggressive goals and add value to shareholders. Precigen’s mission is to improve patient care through innovative gene and cell therapy based approaches.

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About PGEN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on PGEN

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.